To Counter Omicron, Covid-19 Treatments Must Be Cheap and Accessible December 01, 2021 Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Intellectual Property Inventions and Patents IFTTT Molnupiravir (Drug) NYT NYTimes Opinion +